For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2.
EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.
9 December 2020, during an online European Parliament workshop hosted by Sirpa Pietikäinen MEP (Finland), Alzheimer Europe will launch its new report “Dementia as a European Priority – A Policy Overview” which takes stock of dementia policy at an EU… Continue Reading
Alzheimer Europe has launched two new publications: “Intercultural dementia care for health and social care providers: a guide” and “Policy briefing on intercultural care and support for people with dementia and their informal carers/supporters”.
For January 2021, we have selected: M. Obermann et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol 2020, November 24, 2020. https://doi.org/10.1016/S1474-4422(20)30363-X.
Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Prof. Marco Medina, President of the Pan American Federation of Neurological Societies (PAFNS)